Archives of Pharmacal Research

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Antiestrogen, Trans-Tamoxifen Modulation of Human Breast Cancer Cell Growth

  • Published : 1997.12.01
Download PDF
⟨ Previous Next ⟩

Abstract

To gain further insight into how antiestrogens modulate cell function, the effects of antiestrogen on cell proliferation were studied in human breast cancer cells. We examined the effects of trans-tamoxifen on the proliferation of three human breast cancer cell lines that differed in their estrogen receptor contents. Trans-tamoxifen $(1{\mu}M)$ markedly inhibited the estrogen stimulated proliferation of MCF-7 human breast cancer cells that contained high levels of estrogen receptor $(1.15{\pm}0.03 pmole/mg protein)$ over that of control. In T47D cells that contained low levels of estrogen receptor $(0.23{\pm}0.05 pmole/mg protein)$, trans-tamoxifen $(1{\mu}M)$ showed minimal inhibition of estrogen stimulated cell proliferation over that of control. MDA-MB-231 cells, that contained no detectable levels of estrogen receptors, had their growth unaffected by trans-tamoxifen treatment. These results showed their sensitivity to growth inhibition by antiestrogen conrrelated well with their estrogen receptor content. Also we examined the effect of antiestrogen on cellular progestrone receptor level as well as plasminogen activator activity in MCF-7 cells. Trans-tamoxifen $(1{\mu}M)$ showed maximal inhibition of estrogen stimulated progestrone receptor level as well as plasminogen activator activity in MCF-7 cells that were stimulated by estrogen. It is not clear whether these inhibitions of progestrone receptor and plasminogen activator activity by estrogen are related to the antiestrogen inhibition of cell proliferation of MCF-7 cells. From the results of this study, it is clearly demonstrated that trans-tamoxifen is an antiestrogen in MCF-7 human breast cancer cells. Our data suggest that the biological effectiveness of trans-tamoxifen appear to result from its affinity of interaction with the estrogen receptor.

Keywords

References

  1. Recent Results Cancer Res. v.127 What did we learn from the results of the international overview about the effects of endocrine therapy? Bonadonna,G.
  2. Cancer Res. v.43 Steroid stimulation of plasminogen activator production in a human breast cancer cell line (MCF-7) Butler,W.B.;Kirkland,W.L.;Gayala,T.L.;Goran,N.;Kelesey,W.H.;Berkinski,P.J.
  3. Cancer Res. v.46 Use of two MCF-7 cell variants to evaluate the growth regulatory potential of trans-tamoxifen-induced products Davidson,N.E.;Bronzert,D.A.;Chambon,P.;Gelmann,E.P.;Lippman,M.E.
  4. J. Steroid Biochem. Mol. Biol. v.37 Regulation of proliferation, invasion, and growth factor synthesis in breast cancer by steroids Dickson,R.B.;Thompson,E.W.;Lippman,M.E.
  5. Cancer Res. v.42 Effects of transtamoxifens and antitrans-tamoxifens on trans-tamoxifen receptor dynamics and the induction of progesterone receptor in MCF-7 human breast cancer cells Eckert,R.L.;Katzellenbogen,B.S.
  6. Breast Cancer Res. Treat. v.1 Estradiol stimulates synthesis of a major intracellular protein in the human breast cancer cell line MCF-7 Edward,D.P.;Adams,D.J.;McGuire,W.L.
  7. Recent Result Cancer Res. v.127 Adjuvant systemictherapy; overview Henderson,I.C.
  8. J. Biol. Chem. v.253 Nuclear mechanism of estrogen receptor action Horwitz,K.B.;McGuire,W.L.
  9. Breast Cancer Res. and Treatment v.5 Antitrans-tamoxifen action in breast cancer cells Katzellenbogen,B.S.;Miller,M.A.;Mullick,A.;Sheen,Y.Y.
  10. Cancer Res. v.44 Bioactivity estrogen receptor interactions and plasmin activator inducing activities of tamoxifen and hydroxytamoxifen isomers in MCF-7 breast cancer cells Katzellenbogen,B.S.;Norman,M.J.;Eckert,R.L.;Peltz,S.W.;Magel,W.F.
  11. Endocrinology v.111 Uterine plasminogen activator: modulation by steroid hormones Katzellenbogen,B.S.
  12. Nature v.307 Monoclonal antibodies localize trans-tamoxifen receptor in nuclei of target cells King,W.J.;Green,G.L.
  13. Endocrine-dependent Tumors Regulation of growth inhibitory polypeptides in human breast cancer Knabbe,C.;Voigt,K.D.(ed.);Knabbe,C.(ed.)
  14. Biochem. Biophys. Acta v.788 Theory and experimental method for determining kinetic constants of fast-acting irreversible protease inhibitors Kneifel,M.A.;Leytus,S.P.;Fletcher,E.;Weger,T.;Magel,W.F.;Leytus,S.P.;Toledo,D.L.;Mangel,W.F.
  15. Arch. Pharm. Res. Estrogen modulation of breast cancer cells Lee,H.O.;Sheen,Y.Y.
  16. Adv. Intern. Med v.24 Steroid receptor sites in cancer therapy McGuire,W.L.
  17. Adv. Cancer Res. v.17 Mammary neoplasia in mice Nandi,S.;McGrath,C.M.
  18. Ann. NY Acad. Sci. v.51 The attractions of protein for small molecule and ions Schatchard,G.
  19. Endocrinology v.112 Antiestrogen bindig sites are distinct from estrogen receptor Sudo,K.;Mondma,F.J.;Katzellenbogen,B.S.
  20. Cancer Res. v.43 Release of trans-tamoxifen-induced glycoprotein with a molecular weight of 52,000 by breast cancer cells in primary culture Veith,F.O.;Capony,F.;Garcia,M.;Chatelard,J.;Pujol,H.;Veith,F.;Zajdela;Rochefort,H.
  21. Nature v.307 Nuclear localization of unoccupied trans-tamoxifen receptors Welshons,W.V.;Liebeman,M.E.;Gorski,J.
  22. J. Biol. Chem. v.259 Effect of antitrans-tamoxifens on the trans-tamoxifen regulated pS2 RNA and the 52- and 160-kilodalton proteins in MCF-7 cells and two tamoxifen-resistant sublines Westley,B.;May,F.E.B.;Brown,M.C.;Krust,A.;Chambon,P.;Rochefort,F.
  23. Cell v.20 A secreted glycoprotein induced by trans-tamoxifen in human breast cancer cell lines Westley,B.;Rochfort,H.